The statistically significant lower DEC1 staining observed in the FH+ hyperplasia vs that in the FH– hyperplasia suggests that loss or reduced DEC1 expression appears to be an early event in ESCC development in FH+ patients. Here, FH is linked to esophageal squamous cell carcinoma.